help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-1980
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Vargiolu, M.
Right arrow Articles by Bonora, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargiolu, M.
Right arrow Articles by Bonora, E.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 7 2571-2578
Copyright © 2009 by The Endocrine Society

The Tyrosine Kinase Receptor RET Interacts in Vivo with Aryl Hydrocarbon Receptor-Interacting Protein to Alter Survivin Availability

Manuela Vargiolu, Daniela Fusco, Ivana Kurelac, Dietmar Dirnberger, Ralf Baumeister, Isabella Morra, Antonio Melcarne, Roberto Rimondini, Giovanni Romeo and Elena Bonora

Unità di Genetica Medica (M.V., D.F., I.K., G.R., E.B.), Policlinico Universitario S. Orsola-Malpighi, 40138 Bologna, Italy; Bio3/Bioinformatics and Molecular Genetics (Faculty of Biology) (D.D., R.B.), University of Freiburg, 79085 Freiburg, Germany; Center for Biochemistry and Molecular Cell Research (Faculty of Medicine) (R.B.), and Center for Systems Biology (ZBSA) and FRIAS, School of Life Sciences (LIFENET) (R.B.), Albert-Ludwigs-University Freiburg, D79104 Freiburg, Germany; Department of Histopathology (I.M.), Ospedale Infantile Regina Margherita, 10126 Torino, Italy; Department of Neurosurgery (A.M.), A.S.O. CTO-CRF-M.Adelaide, 10131 Torino, Italy; and Department of Pharmacology (R.R.), University of Bologna, 40126 Bologna, Italy

Address all correspondence and requests for reprints to: Giovanni Romeo, Unità di Genetica Medica Policlinico Universitario S. Orsola-Malpighi, 40138 Bologna, Italy. E-mail: romeo{at}eurogene.org.

Context: RET is a tyrosine kinase transmembrane receptor expressed in two main alternative isoforms: RET9 and RET51. RET transduces a positive signal leading to survival, differentiation, or migration in the presence of its ligand glial cell line-derived neurotrophic factor, whereas in its absence a proapoptotic fragment that initiates a negative signaling for apoptosis is generated. The signal transduction mechanisms leading to apoptosis are still unclear.

Objective: To shed light on the mechanisms of RET-induced apoptosis, we searched for novel interactors of RET51.

Design: The "split ubiquitin yeast two-hybrid system" was used with RET51 as bait against a human brain expression library.

Results: We identified aryl hydrocarbon receptor-interacting protein (AIP), a cochaperone recently found mutated in pituitary adenoma patients, as a novel interactor of RET. We showed that RET interacts specifically with AIP both in mammalian cell lines and in vivo in the pituitary gland, regardless of the presence of pituitary adenoma-specific mutations. AIP and RET genes were sequenced in 28 pituitary adenoma, but no relevant mutations were found. In addition, we identified the proapoptotic domain of RET as responsible for the interaction with AIP. Finally, we demonstrated that the AIP-RET interaction does not require RET kinase activity or kinase-dependent signal transduction and that it prevents the formation of the AIP-survivin complex.

Conclusions: The identification of the AIP-RET complex represents a starting point to study key cellular processes involved in RET-induced apoptosis.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. E Jennings, M. Georgitsi, I. Holdaway, A. F Daly, M. Tichomirowa, A. Beckers, L. A Aaltonen, A. Karhu, and F. J Cameron
Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene
Eur. J. Endocrinol., November 1, 2009; 161(5): 799 - 804.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M.-L. Jaffrain-Rea, M. Angelini, D. Gargano, M. A Tichomirowa, A. F Daly, J.-F. Vanbellinghen, E. D'Innocenzo, A. Barlier, F. Giangaspero, V. Esposito, et al.
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
Endocr. Relat. Cancer, September 1, 2009; 16(3): 1029 - 1043.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society